Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial-Reference-Cited by-同舟云学术

Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial

Published:2017-06 Issue:6 Volume:197 Page:1441-1447
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Østergren Peter B.¹²,Kistorp Caroline³²,Fode Mikkel¹,Henderson James⁴,Bennedbæk Finn N.³²,Faber Jens³²,Sønksen Jens¹²

Affiliation:

1. Department of Urology, Herlev and Gentofte University Hospital, Herlev, Denmark

2. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

3. Department of Endocrinology, Herlev and Gentofte University Hospital, Herlev, Denmark

4. Department of Urology, University of Michigan, Ann Arbor, Michigan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Contemporary role of androgen deprivation therapy for prostate cancer;Pagliarulo;Eur Urol,2012

2. Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?;Perachino;BJU Int,2010

3. Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer;Bertaglia;Clin Genitourin Cancer,2013

4. Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT;Klotz;J Clin Oncol,2015

5. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy;Morote;J Urol,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Quality of Life and Sexual Function After Luteinizing Hormone‐Releasing Hormone (LHRH) Agonists and Orchiectomy in Men With Metastatic Prostate Cancer: Results From a Randomized Trial;Cureus;2024-03-11

2. Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression;The Journal of Clinical Endocrinology & Metabolism;2023-05-26

3. Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review;Frontiers in Endocrinology;2023-02-06

4. Complete androgen blockade vs. medical castration alone as adjuvant androgen deprivation therapy for prostate cancer patients following radical prostatectomy: a retrospective cohort study;Chinese Medical Journal;2022-02-28

5. Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety;Indian Journal of Cancer;2022